Terug
39
Ook genoteerd als
SNNUF
OTC
Dagbereik
€ 32,06
€ 32,39
52-Weeksbereik
€ 23,91
€ 38,79
Volume
601.676
50D / 200D Gem.
€ 34,35
/
€ 33,93
Vorige Slotkoers
€ 31,94
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 21,8 | 0,4 |
| P/B | 2,6 | 2,9 |
| ROE % | 11,9 | 3,9 |
| Net Margin % | 10,1 | 3,8 |
| Rev Growth 5Y % | 4,3 | 10,0 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Hold
€ 37,50
+16.6%
Forward K/W
14,30
Forward WPA
€ 2,23
WPA Groei (sch.)
+0,0%
Omzet Sch.
6,59B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,16
€ 3,06 – € 3,24
|
8,32B | 1 |
| FY2029 |
€ 2,95
€ 2,85 – € 3,02
|
7,76B | 1 |
| FY2028 |
€ 2,75
€ 2,66 – € 2,82
|
7,34B | 1 |
No quarterly estimates available
Dividend History
Yield
0,02%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 4,34% annually over 5 years — modest growth
Earnings grew 52,05% over the past year
ROE of 11,87% — decent returns on equity
Generating 853,99M in free cash flow
PEG of 0,41 suggests growth is underpriced
Cash machine — converts 136,32% of earnings into free cash flow
Groei
Revenue Growth (5Y)
4,34%
Revenue (1Y)6,34%
Earnings (1Y)52,05%
FCF Growth (3Y)117,21%
Kwaliteit
Return on Equity
11,87%
ROIC8,75%
Net Margin10,14%
Op. Margin16,27%
Veiligheid
Debt / Equity
0,63
Current Ratio2,57
Interest Coverage6,43
Waardering
P/E Ratio
21,83
Forward P/EN/A
P/B Ratio2,59
EV/EBITDA16,36
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,34% | Revenue Growth (3Y) | 5,52% |
| Earnings Growth (1Y) | 52,05% | Earnings Growth (3Y) | 54,34% |
| Revenue Growth (5Y) | 4,34% | Earnings Growth (5Y) | 4,57% |
| Profitability | |||
| Revenue (TTM) | 6,18B | Net Income (TTM) | 626,46M |
| ROE | 11,87% | ROA | 5,99% |
| Gross Margin | 68,01% | Operating Margin | 16,27% |
| Net Margin | 10,14% | Free Cash Flow (TTM) | 853,99M |
| ROIC | 8,75% | FCF Growth (3Y) | 117,21% |
| Safety | |||
| Debt / Equity | 0,63 | Current Ratio | 2,57 |
| Interest Coverage | 6,43 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 21,83 | Forward P/E | N/A |
| P/B Ratio | 2,59 | P/S Ratio | 2,21 |
| PEG Ratio | 0,41 | Forward PEG | N/A |
| EV/EBITDA | 16,36 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 6,25% | ||
| Market Cap | 13,67B | Enterprise Value | 16,44B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6,18B | 5,81B | 5,55B | 5,22B | 5,21B |
| Net Income | 626,46M | 412,00M | 263,00M | 223,00M | 524,00M |
| EPS (Diluted) | 1,44 | 0,94 | 1,20 | 0,50 | 1,20 |
| Gross Profit | 4,20B | 4,05B | 3,82B | 3,68B | 3,67B |
| Operating Income | 1,01B | 657,00M | 425,00M | 315,00M | 593,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 10,46B | 10,35B | 9,99B | 9,97B | 10,92B |
| Total Liabilities | 5,17B | 5,09B | 4,77B | 4,71B | 5,35B |
| Shareholders' Equity | 5,29B | 5,27B | 5,22B | 5,26B | 5,57B |
| Total Debt | 3,33B | 3,32B | 3,08B | 2,87B | 3,34B |
| Cash & Equivalents | 557,00M | 619,00M | 302,00M | 350,00M | 1,29B |
| Current Assets | 4,10B | 4,42B | 4,03B | 3,86B | 4,42B |
| Current Liabilities | 1,60B | 1,53B | 2,27B | 1,72B | 2,13B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#664 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026